Arrowhead Pharmaceuticals announced that the AlphaGenome platform will connect genome-wide functional predictions with mutation types, news, and causal evidence to inform therapeutic decisions.
Published
Signal category
Products & Services
Quote
โThe next step for ๐๐น๐ฝ๐ต๐ฎ๐๐ฒ๐ป๐ผ๐บ๐ฒ ๐๐๐น๐ฎ๐ is to connect these genome-wide functional predictions with ๐ต๐๐บ๐ฎ๐ป ๐ฝ๐ต๐ฒ๐ป๐ผ๐๐๐ฝ๐ฒ, ๐๐ถ๐๐๐๐ฒ ๐ฐ๐ผ๐ป๐๐ฒ๐ ๐, and ๐ฐ๐ฎ๐๐๐ฎ๐น ๐ฒ๐๐ถ๐ฑ๐ฒ๐ป๐ฐ๐ฒโ
โ Shicheng Guo|Arrowhead Pharmaceuticals team
Company
- Industry
- Biotechnology Research
- Location
- Pasadena, US
- Company size
- 930 employees
At Arrowhead Pharmaceuticals we are breaking the mold of medicine. We are pushing the boundaries of therapeutic development and revolutionizing how we care for hard-to-treat illnesses. As a company we harness collaboration and innovation to rapidly advance drugs from discovery to the clinic. All applicants: Please be aware of employment scams using Arrowheadโs name and the names of Arrowheadโs employees. All job related Arrowhead communication should come from the domain @arrowheadpharma.com.